13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001535610
Total reported value
$110.5M
$110.5M
43 檔
8.8%
The Q2 2025 SEC filing reveals that Sabby Management, LLC held a total portfolio value of $110.5M, covering 43 public equity positions.
In Q2 2025, Sabby Management, LLC adopted a defensive or profit-taking posture, trimming 14 positions and completely liquidating 31 holdings to manage risk exposure.
In terms of portfolio concentration, the top 5 core holdings (including EOS ENERGY ENTERPRISES INC, TPST, EOSE) accounted for 8.8% of total reported equity market value during Q2 2025.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Eos Energy Enterprises Inc | Stock-Other | 21.41% | — | -20.18% | |
| 2 | TPST | Tempest Therapeutics Inc | Stock-Other | 10.21% | +0.18% | — | |
| 3 | EOSE | Eos Energy Enterprises Inc | Stock-Other | 9.51% | — | -50.08% | |
| 4 | LYRA | Lyra Therapeutics Inc | Stock-Other | 6.11% | -0.57% | EXIT | |
| 5 | LEXX | Lexaria Bioscience CORP | Stock-Other | 5.50% | — | — | |
| 6 | ✓ | Can Fite Biofarma LTD | Stock-Other | 4.44% | — | — | |
| 7 | CLSNEUR | Imunon Inc | Stock-Other | 3.91% | — | — | |
| 8 | ✓ | Bit Digital Inc | Stock-Other | 3.59% | — | — | |
| 9 | ✓ | Bit Digital Inc | Stock-Other | 3.51% | — | -37.10% | |
| 10 | BCTXZ | Briacell Therapeutics - 30 | Stock-Other | 3.44% | -0.31% | — | |
| 11 | ✓ | Stock-Other | 2.45% | — | — | ||
| 12 | IWM | Ishares Russell 2000 ETF | ETF-Small Cap | 2.35% | — | -90.51% | |
| 13 | ✓ | Iterum Therapeutics PLC | Stock-Other | 2.33% | — | — | |
| 14 | XTIA | Xti Aerospace Inc | Stock-Other | 2.17% | — | -23.68% | |
| 15 | SUNE | Sunation Energy Inc | Stock-Other | 1.94% | — | — | |
| 16 | ✓ | Chanson Intl Hldg | Stock-Other | 1.54% | — | — | |
| 17 | ✓ | Stock-Other | 1.37% | — | — | ||
| 18 | ✓ | Snow Lake Res LTD | Stock-Other | 1.24% | — | — | |
| 19 | ✓ | Core Scientific Inc New | Stock-Other | 1.20% | — | — | |
| 20 | ✓ | Akari Therapeutics PLC | Stock-Other | 1.14% | — | — | |
| 21 | ✓ | Digital Ally Inc | Stock-Other | 1.01% | — | — | |
| 22 | ✓ | Ishares Tr | Stock-Other | 1.00% | +11.16% | -29.17% | |
| 23 | ✓ | Bluejay Diagnostics Inc | Stock-Other | 0.90% | — | — | |
| 24 | ✓ | Realpha Tech CORP | Stock-Other | 0.87% | — | — | |
| 25 | ✓ | Eos Energy Enterprises Inc | Stock-Other | 0.68% | — | — | |
| 26 | BNBX | Bnb Plus CORP | Stock-Other | 0.68% | -0.10% | EXIT | |
| 27 | VANI | Vivani Medical Inc | Stock-Other | 0.66% | — | -88.98% | |
| 28 | ✓ | Briacell Therapeutics CORP | Stock-Other | 0.63% | — | — | |
| 29 | ✓ | Spdr S&P 500 Etf Tr Put Option | ETF-Large Cap & Growth | 0.62% | +45.73% | -34.97% | |
| 30 | EMPD | Empery Digital Inc | Stock-Other | 0.60% | — | — | |
| 31 | ✓ | Stock-Other | 0.59% | — | — | ||
| 32 | ✓ | Zevra Therapeutics Inc | Stock-Other | 0.51% | -3.00% | -85.98% | |
| 33 | ✓ | Reviva Pharmaceutcls Hldgs I | Stock-Other | 0.35% | — | — | |
| 34 | SPY | State Street SPDR S&P 500 ETF Trust | ETF-Large Cap & Growth | 0.34% | +13.85% | NEW | |
| 35 | ✓ | Stock-Other | 0.27% | — | — | ||
| 36 | ✓ | Suncar Technology Group Inc | Stock-Other | 0.25% | — | — | |
| 37 | ACXPEUR | Acurx Pharmaceuticals Inc | Stock-Other | 0.23% | — | -95.99% | |
| 38 | ✓ | Nuwellis Inc | Stock-Other | 0.18% | — | — | |
| 39 | ✓ | Stock-Other | 0.12% | — | -91.77% | ||
| 40 | ✓ | Stock-Other | 0.06% | — | -86.20% | ||
| 41 | CORZ | Core Scientific, Inc. | Stock-Tech | 0.06% | — | — | |
| 42 | ✓ | Reviva Pharmaceutcls Hldgs Inc | Stock-Other | 0.05% | — | -98.06% | |
| 43 | ✓ | Stock-Other | 0.01% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Eos Energy Enterprises Inc | +16.9% | -20.18% | Trim |
| 2 | TPST | Tempest Therapeutics Inc | +10.2% | NEW | New buy |
| 3 | LYRA | Lyra Therapeutics Inc | +6.1% | NEW | New buy |
| 4 | LEXX | Lexaria Bioscience CORP | +5.5% | NEW | New buy |
| 5 | ✓ | Can Fite Biofarma LTD | +4.4% | NEW | New buy |
| 6 | CLSNEUR | Imunon Inc | +3.9% | NEW | New buy |
| 7 | ✓ | Bit Digital Inc | +3.6% | NEW | New buy |
| 8 | BCTXZ | Briacell Therapeutics - 30 | +3.4% | NEW | New buy |
| 9 | ✓ | +2.5% | NEW | New buy | |
| 10 | ✓ | Iterum Therapeutics PLC | +2.3% | NEW | New buy |
| 11 | SUNE | Sunation Energy Inc | +1.9% | NEW | New buy |
| 12 | EOSE | Eos Energy Enterprises Inc | +1.6% | -50.08% | Trim |
| 13 | ✓ | Chanson Intl Hldg | +1.5% | NEW | New buy |
| 14 | ✓ | +1.4% | NEW | New buy | |
| 15 | ✓ | Snow Lake Res LTD | +1.2% | NEW | New buy |
| 16 | ✓ | Core Scientific Inc New | +1.2% | NEW | New buy |
| 17 | ✓ | Akari Therapeutics PLC | +1.1% | NEW | New buy |
| 18 | XTIA | Xti Aerospace Inc | +1.1% | -23.68% | Trim |
| 19 | ✓ | Digital Ally Inc | +1% | NEW | New buy |
| 20 | ✓ | Bluejay Diagnostics Inc | +0.9% | NEW | New buy |
| 21 | ✓ | Realpha Tech CORP | +0.9% | NEW | New buy |
| 22 | ✓ | Eos Energy Enterprises Inc | +0.7% | NEW | New buy |
| 23 | BNBX | Bnb Plus CORP | +0.7% | NEW | New buy |
| 24 | ✓ | Briacell Therapeutics CORP | +0.6% | NEW | New buy |
| 25 | ✓ | Bit Digital Inc | +0.6% | -37.10% | Trim |
| 26 | EMPD | Empery Digital Inc | +0.6% | NEW | New buy |
| 27 | ✓ | +0.6% | NEW | New buy | |
| 28 | ✓ | Reviva Pharmaceutcls Hldgs I | +0.4% | NEW | New buy |
| 29 | SPY | State Street SPDR S&P 500 ETF Trust | +0.3% | -9.09% | Trim |
| 30 | ✓ | +0.3% | NEW | New buy | |
| 31 | ✓ | Nuwellis Inc | +0.2% | NEW | New buy |
| 32 | CORZ | Core Scientific, Inc. | +0.1% | NEW | New buy |
| 33 | ✓ | Suncar Technology Group Inc | 0% | — | Unchanged |
| 34 | ✓ | 0% | NEW | New buy | |
| 35 | ✓ | Agm Group Holdings Inc | 0% | EXIT | Sold out |
| 36 | ✓ | Globus Maritime Limited New | 0% | EXIT | Sold out |
| 37 | KPRX | Kiora Pharmaceuticals Inc | -0.1% | EXIT | Sold out |
| 38 | ✓ | Checkpoint Therapeutics Inc | -0.1% | EXIT | Sold out |
| 39 | SCPX | Scorpius Holdings Inc | -0.1% | EXIT | Sold out |
| 40 | SIDU | Sidus Space Inc-cl A | -0.1% | EXIT | Sold out |
| 41 | ✓ | -0.2% | EXIT | Sold out | |
| 42 | ✓ | Ishares Tr | -0.3% | -29.17% | Trim |
| 43 | ✓ | Allurion Technologies Inc | -0.3% | EXIT | Sold out |
| 44 | ✓ | Spdr S&P 500 Etf Tr Put Option | -0.3% | -34.97% | Trim |
| 45 | ✓ | -0.4% | EXIT | Sold out | |
| 46 | ✓ | TransCode Therapeutics Inc | -0.4% | EXIT | Sold out |
| 47 | ENSC | Ensysce Biosciences Inc | -0.4% | EXIT | Sold out |
| 48 | ✓ | -0.4% | EXIT | Sold out | |
| 49 | NNOX | Nano-X Imaging Ltd. | -0.4% | EXIT | Sold out |
| 50 | ✓ | -0.4% | -91.77% | Trim |
According to official SEC Form 13F filings, Sabby Management, LLC reported a total U.S. public equity portfolio value of $110.5M across 43 disclosed positions in Q2 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Top New Position Initiated
TPST
市值: $1.9M
Top Position Liquidated / Trimmed
SRFM
前期市值: $4.7M
During Q2 2025, Sabby Management, LLC's top holdings by market value included EOS ENERGY ENTERPRISES INC (21.4%)、TPST (10.2%)、EOSE (9.5%). The largest single position, EOS ENERGY ENTERPRISES INC, represented 21.4% of total portfolio value.
In Q2 2025, Sabby Management, LLC made 73 total portfolio adjustments, initiating 28 new buys, adding to 0 positions, trimming 14 holdings, and fully liquidating 31 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.